NEUROCOGNITIVE FUNCTIONING IN EORTC BRAIN TUMOR GROUP RANDOMIZED PHASE II TAVAREC TRIAL (EORTC 26091, NCT01164189) ON TEMOZOLOMIDE WITH OR WITHOUT BEVACIZUMAB in 1p/19q INTACT RECURRENT GRADE II AND III GLIOMAS
| Autor: | Klein, M., Reijneveld, J.C., Idbaih, A., Taal, W., Clement, P.M., Vos, F. de, Wick, A., Mulholland, P., Taphoorn, M.J.B., Lewis, J., Weller, M., Verschuere, T., Golfinopoulos, V., Gorlia, T., Bent, M. van den |
|---|---|
| Přispěvatelé: | Amsterdam Neuroscience - Mood, Anxiety, Psychosis, Stress & Sleep, CCA - Imaging and biomarkers, CCA - Treatment and quality of life, NCA - Neurobiology of mental health, Medical psychology, Neurology |
| Jazyk: | angličtina |
| Rok vydání: | 2017 |
| Zdroj: | Klein, M, Reijneveld, J C, Idbaih, A, Taal, W, Clement, P M, de Vos, F, Wick, A, Mulholland, P, Taphoorn, M J B, Lewis, J, Weller, M, Verschuere, T, Golfinopoulos, V, Gorlia, T & van den Bent, M 2017, ' NEUROCOGNITIVE FUNCTIONING IN EORTC BRAIN TUMOR GROUP RANDOMIZED PHASE II TAVAREC TRIAL (EORTC 26091, NCT01164189) ON TEMOZOLOMIDE WITH OR WITHOUT BEVACIZUMAB in 1p/19q INTACT RECURRENT GRADE II AND III GLIOMAS ', Neuro-Oncology, vol. 19, pp. 139-139 . Neuro-Oncology, 19, 139-139. Oxford University Press Neuro-Oncology, 19, 139-139 |
| ISSN: | 1522-8517 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|